Nasal Drug Delivery Market Size, Share, Opportunities, And Trends By Dosage Form (Nasal Spray, Nasal Drops, Nasal Ointment, Others), By Application (Disease Treatment, Research/Academic purposes), And By Geography - Forecasts From 2025 To 2030
- Published : May 2025
- Report Code : KSI061614741
- Pages : 147
Nasal Drug Delivery Market Size:
The Nasal Drug Delivery Market is expected to grow from US$73.465 billion in 2025 to US$100.323 billion in 2030, at a CAGR of 6.43%.
Nasal drug delivery is referred to the transfer of drugs into the human body through an intranasal route of administration. These are in high demand owing to the convenience of administration in addition to providing improved patient compliance. Also, there are certain drugs that are not suitable for oral or parenteral administration, thus, calling for the need for nasal drug delivery systems. Furthermore, rising R&D investment, and growing health expenditure are driving the growth of the global nasal drug delivery market in the forecast period.
Nasal Drug Delivery Market Drivers:
- Non-suitability of certain drugs via the oral or parenteral route of administration.
- Increasing health expenditure worldwide.
Nasal Drug Delivery Market Restraints:
- Stringent regulations regarding the approval of drugs and medical devices.
The major players profiled in the nasal drug delivery market include OptiNose, Inc., Korten Pharmaceuticals Pvt. Ltd., Catalent, Inc, Cipla Inc., and Perrigo Company plc.
Nasal Drug Delivery Market Scope:
Report Metric | Details |
Nasal Drug Delivery Market Size in 2025 | US$73.465 billion |
Nasal Drug Delivery Market Size in 2030 | US$100.323 billion |
Growth Rate | CAGR of 6.43% |
Study Period | 2020 to 2030 |
Historical Data | 2020 to 2023 |
Base Year | 2024 |
Forecast Period | 2025 – 2030 |
Forecast Unit (Value) | USD Billion |
Segmentation |
|
Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
List of Major Companies in Nasal Drug Delivery Market |
|
Customization Scope | Free report customization with purchase |
The nasal drug delivery market is analyzed into the following segments:
By Dosage Form
Nasal Spray
Nasal Drops
Nasal Ointment
Others
By Application
Disease Treatment
Research/Academic purposes
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
Frequently Asked Questions (FAQs)
Q1. What will be the nasal drug delivery market size by 2024?
A1. The nasal drug delivery market is projected to reach a total market size of US$76.083 billion by 2024.
Q2. What is the size of global nasal drug delivery market?
A2. Nasal Drug Delivery market was valued at US$51.917 billion in 2018.
Q3. What are the growth prospects for nasal drug delivery market?
A3. The global nasal drug delivery market is projected to grow at a CAGR of 6.58% over the forecast period.
Q4. What factors are anticipated to drive the nasal drug delivery market growth?
A4. Rising R&D investment, growing health expenditure are driving the growth of the global nasal drug delivery market in the forecast period.
Q5. Who are the major players in the nasal drug delivery market?
A5. The major players profiled in the nasal drug delivery market include OptiNose, Inc., Korten Pharmaceuticals Pvt. Ltd., Catalent, Inc, Cipla Inc., and Perrigo Company plc.
Frequently Asked Questions (FAQs)
The nasal drug delivery market is expected to reach a total market size of US$100.323 billion by 2030.
Nasal Drug Delivery Market is valued at US$73.465 billion in 2025.
The nasal drug delivery market is expected to grow at a CAGR of 6.43% during the forecast period.
The North American region is anticipated to hold a significant share of the nasal drug delivery market.
The nasal drug delivery market is expected to grow due to rising demand for non-invasive treatments, advancements in nasal spray tech, and increasing prevalence of chronic diseases.
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NASAL DRUG DELIVERY MARKET BY DOSAGE FORM
5.1. Nasal Spray
5.2. Nasal Drops
5.3. Nasal Ointment
5.4. Others
6. NASAL DRUG DELIVERY MARKET BY APPLICATION
6.1. Disease Treatment
6.2. Research/Academic purposes
7. NASAL DRUG DELIVERY MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. UAE
7.4.3. Israel
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. India
7.5.3. Australia
7.5.4. South Korea
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Company Benchmarking and Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. OptiNose, Inc.
9.2. Korten Pharmaceuticals Pvt. Ltd.
9.3. Catalent, Inc
9.4. Cipla Inc.
9.5. Perrigo Company plc
LIST OF FIGURES
LIST OF TABLES
Related Reports
Report Name | Published Month | Download Sample |
---|---|---|
Pulmonary Drug Delivery Systems Market: Size, Trends, Forecast 2030 | May 2025 | |
Drug Delivery Polymer Market Insights: Size, Share, Forecast 2030 | Jun 2025 | |
Inhalation Drug Delivery Market Size, Share, Trends, Forecast 2030 | May 2025 | |
Injectable Drug Delivery Market Report: Share, Forecast 2030 | Dec 2024 | |
Oral Drug Delivery Market Insights: Size, Trends, Forecast 2030 | Mar 2025 |